beta drugs limited (beta) gets regulatory approval ✌️【High Risk, High Return】✌️ Professional investment advisors provide real-time market data to help you analyze stock trends and select high-potential stocks, increasing capital growth. beta drugs limited (beta) gets regulatory approval - Free Professional Portfolio Management ✌️【High Risk, High Return】✌️ Precise stock market trend predictions with free real-time quotes for India stocks, US stocks, and European stocks to help you seize the best investment timing.

beta drugs limited (beta) gets regulatory approval ✌️【High Risk, High Return】✌️ Professional investment advisors provide real-time market data to help you analyze stock trends and select high-potential stocks, increasing capital growth. Today on the show, Fareed is joined by an expert panel to break down the results of Tuesday’s presidential election. New York Times opinion columnist Ezra Klein and Atlantic staff writer David Frum discuss the realignment of the American electorate that led to a sweeping Trump victory, and what Democrats need to do to build a durable and lasting coalition moving forward.Â

beta drugs limited (beta) gets regulatory approval ✌️【High Risk, High Return】✌️ Expert predictions of stock trends with real-time stock indices, metals, energy, and agricultural product data to help you make efficient investment decisions. Next, Oren Cass, founder and chief economist at the conservative think tank American Compass, joins the show to discuss the populist turn within the Republican Party, and what the GOP’s agenda may look like under a second Trump presidency.

Finally, The Economist editor-in-chief Zanny Minton Beddoes speaks with Fareed about the impact of the US election on the rest of the world, from Mexico to China, the Middle East to Ukraine and the rest of Europe.Â

GUESTS: Ezra Klein (@ezraklein); David Frum (@davidfrum); Oren Cass (@oren_cass); Zanny Minton Beddoes (@zannymb)Â